Hepatitis Monthly

Published by: Kowsar

Association of TNF-α Gene Polymorphisms with Production of Protein and Susceptibility to Chronic Hepatitis B Infection in the South East Iranian Population

Zahra Heidari 1 , 2 , Bita Moudi 1 , 2 , * , Hamidreza Mahmoudzadeh Sagheb 1 , 2 and Mehrnoosh Moudi 3
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
2 Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
3 Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
Article information
  • Hepatitis Monthly: November 01, 2016, 16 (11); e41984
  • Published Online: October 30, 2016
  • Article Type: Research Article
  • Received: September 4, 2016
  • Revised: October 1, 2016
  • Accepted: October 17, 2016
  • DOI: 10.5812/hepatmon.41984

To Cite: Heidari Z, Moudi B, Mahmoudzadeh Sagheb H, Moudi M. Association of TNF-α Gene Polymorphisms with Production of Protein and Susceptibility to Chronic Hepatitis B Infection in the South East Iranian Population, Hepat Mon. 2016 ;16(11):e41984. doi: 10.5812/hepatmon.41984.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[PubMed]
  • 2. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat. 2005; 12(2): 111-24[DOI][PubMed]
  • 3. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, et al. Hepatitis B virus markers in Chinese twins. Anticancer Res. 1989; 9(3): 737-41[PubMed]
  • 4. Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, Chakraborty M, et al. Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res. 2003; 13(10): 2277-90[DOI][PubMed]
  • 5. Huang YH, Tao MH, Hu CP, Syu WJ, Wu JC. Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus. J Gen Virol. 2004; 85: 3089-98[DOI][PubMed]
  • 6. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M. Association between IL-10 gene promoter polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and susceptibility to HBV infection in an Iranian population. Hepat Mon. 2016; 16(2)[DOI]
  • 7. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H. Impact of host gene polymorphisms on susceptibility to chronic hepatitis B virus infection. Infect Genet Evol. 2016; 44: 94-105[DOI][PubMed]
  • 8. Heidari Z, Moudi B, Mahmoudzadeh-Sagheb H, Hashemi M. The Correlation between Interferon Lambda 3 Gene Polymorphisms and susceptibility to Hepatitis B Virus Infection. Hepat Mon. 2016; 16(3): 34266[DOI]
  • 9. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M. Gene polymorphisms of macrophage migration inhibitory factor affect susceptibility to chronic hepatitis B virus infection in an Iranian cohort. Microbiol Immunol. 2016; 60(6): 390-6[DOI][PubMed]
  • 10. Takakura M, Tokushige K, Matsushita N, Hashimoto E, Shiratori K. Possible involvement of cytokine gene polymorphisms in fulminant hepatitis. J Gastroenterol Hepatol. 2007; 22(8): 1271-7[DOI][PubMed]
  • 11. Gratchev A, Schledzewski K, Guillot P, Goerdt S. Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. Skin Pharmacol Appl Skin Physiol. 2001; 14(5): 272-9[PubMed]
  • 12. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A. 1998; 95(16): 9465-70[PubMed]
  • 13. Koulentaki M, Notas G, Petinaki E, Valatas V, Mouzas IA, Castanas E, et al. Nitric oxide and pro-inflammatory cytokines in acute hepatitis B. Eur J Intern Med. 2004; 15(1): 35-8[DOI][PubMed]
  • 14. Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat. 2005; 12(1): 38-45[DOI][PubMed]
  • 15. Horie Y, Chiba M, Suzuki T, Kudo T, Kamata A, Iizuka M, et al. Induction of major histocompatibility complex class II antigens on human colonic epithelium by interferon-gamma, tumor necrosis factor-alpha, and interleukin-2. J Gastroenterol. 1998; 33(1): 39-47[PubMed]
  • 16. Cavanaugh VJ, Guidotti LG, Chisari FV. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol. 1998; 72(4): 2630-7[PubMed]
  • 17. Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M, Rigi Ladez MA. Stereological analysis of interdental gingiva in chronic periodontitis patients with tumor necrosis factor alpha (-308g/a) gene polymorphisms. Gene Cell Tissue. 2014; 1(1): 18315[DOI]
  • 18. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995; 99(2): 303-10[PubMed]
  • 19. Heidari Z. The Association Between Proinflammatory Gene Polymorphisms and Level of Gingival Tissue Degradation in Chronic Periodontitis. Gene Cell Tissue. 2014; 1(2)[DOI]
  • 20. Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Quinones-Berrocal J, et al. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun. 2002; 3(8): 482-7[DOI][PubMed]
  • 21. Heesen M, Kunz D, Wessiepe M, van der Poll T, Zwinderman AH, Blomeke B. Rapid genotyping for tumor necrosis factor-alpha (TNF-alpha)-863C/A promoter polymorphism that determines TNF-alpha response. Clin Chem. 2004; 50(1): 226-8[DOI][PubMed]
  • 22. Velayati AA, Farnia P, Farahbod AM, Afraei Karahrudi M, Derakhshaninezhad Z, Kazampour M. Association of Receptors, Purinergic P2X7 and Tumor Necrosis Factor-Alpha Gene Polymorphisms in Susceptibility to Tuberculosis Among Iranian Patients. Arch Clin Infect Dis. 2013; 8(3): 16087[DOI]
  • 23. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol. 1998; 111(3): 579-82[PubMed]
  • 24. Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet. 2003; 12(19): 2541-6[DOI][PubMed]
  • 25. Fidder HH, Heijmans R, Chowers Y, Bar-Meir S, Avidan B, Pena AS, et al. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease. Int J Immunogenet. 2006; 33(2): 81-5[DOI][PubMed]
  • 26. Lin CL, Kao JH. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci. 2008; 15(2): 137-45[DOI][PubMed]
  • 27. Koziel MJ. Cytokines in viral hepatitis. Semin Liver Dis. 1999; 19(2): 157-69[DOI][PubMed]
  • 28. Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MB, et al. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci U S A. 1996; 93(10): 4589-94[PubMed]
  • 29. Buke AC, Buke M, Altuglu IE, Ciceklioglu M, Kamcioglu S, Karakartal G, et al. Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection. Med Princ Pract. 2004; 13(5): 273-6[DOI][PubMed]
  • 30. Puro R, Schneider RJ. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol. 2007; 81(14): 7351-62[DOI][PubMed]
  • 31. Shaw BE, Maldonado H, Madrigal JA, Smith C, Petronzelli F, Mayor NP, et al. Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue Antigens. 2004; 63(5): 401-11[DOI][PubMed]
  • 32. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet. 2003; 33(4): 469-75[DOI][PubMed]
  • 33. Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology. 2005; 115(1): 1-20[DOI][PubMed]
  • 34. Du T, Guo XH, Zhu XL, Li JH, Lu LP, Gao JR, et al. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J Viral Hepat. 2006; 13(9): 618-24[DOI][PubMed]
  • 35. Lu LP, Li XW, Liu Y, Sun GC, Wang XP, Zhu XL. Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol. 2004; 10(12): 1810-4[DOI]
  • 36. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics. 1994; 39(2): 150-4[PubMed]
  • 37. Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect Genet Evol. 2008; 8(1): 20-5[DOI][PubMed]
  • 38. Xu J, Zhang S, Zhang Z, Fu L, Zheng Q, Wang J, et al. TNF-alpha promoter region polymorphisms affect HBV virus clearance in southern Chinese. Clin Chim Acta. 2013; 425: 90-2[DOI][PubMed]
  • 39. Xia Q, Zhou L, Liu D, Chen Z, Chen F. Relationship between TNF-<alpha> gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis. PLoS One. 2011; 6(5): 19606[DOI][PubMed]
  • 40. Zheng MH, Qiu LX, Xin YN, Pan HF, Shi KQ, Chen YP. Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations. Int J Infect Dis. 2010; 14(7)-5[DOI][PubMed]
  • 41. Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, et al. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population. Gene. 2015; 568(2): 140-5[DOI][PubMed]
  • 42. Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, et al. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia. 2007; 9(11): 987-92[PubMed]
  • 43. Wang B, Wang J, Zheng Y, Zhou S, Zheng J, Wang F, et al. A study of TNF-alpha-238 and -308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China. Pathology. 2010; 42(7): 674-80[DOI][PubMed]
  • 44. Somi MH, Najafi L, Noori BN, Alizadeh AH, Aghah MR, Shavakhi A. Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B. Indian J Gastroenterol. 2006; 25(1): 14-5
  • 45. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998; 51(6): 605-12[PubMed]
  • 46. van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet. 2002; 11(11): 1281-9[PubMed]
  • 47. Hohjoh H, Tokunaga K. Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun. 2001; 2(2): 105-9[DOI][PubMed]
  • 48. Zhang TC, Zhao YQ, Hu GL, Liu XQ, Huang XK. The relationship between tumour necrosis factor-alpha gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in a Chinese population: a meta-analysis. Clin Microbiol Infect. 2014; 20(3): 227-34[DOI][PubMed]
  • 49. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999; 8(8): 1443-9[PubMed]
  • 50. Sharma S, Sharma A, Kumar S, Sharma SK, Ghosh B. Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am J Respir Cell Mol Biol. 2006; 35(4): 488-95[DOI][PubMed]
  • 51. Skoog T, Hamsten A, Eriksson P. Allele-specific chromatin remodeling of the tumor necrosis factor-alpha promoter. Biochem Biophys Res Commun. 2006; 351(3): 777-83[DOI][PubMed]
  • 52. Gao J, Zou H, Li Z. Effect of TNF-α promoter region polymorphisms on outcome in northern Han population with HBV infection. Beijing Med. 2010; 32: 699-702
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments